Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bally

Showing results (211-220 of 225) with videos related to

Pageof 23
Sort By:
Inorganic Chemistry|December 15, 2015
Induction of Cytotoxicity in Pyridine Analogues of the Anti-metastatic Ru(III) Complex NAMI-A by Ferrocene FunctionalizationChanghua Mu, Stephanie W Chang, Kathleen E Prosser, et al.
BMC Cancer|October 4, 2011
The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivityWieslawa H Dragowska, Sherry A Weppler, Mohammed A Qadir, et al.
Magnetic Resonance in Medicine|October 10, 2006
Chemodosimetry of in vivo tumor liposomal drug concentration using MRIBenjamin L Viglianti, Ana M Ponce, Charles R Michelich, et al.
Plos One|October 23, 2013
Induction of autophagy is an early response to gefitinib and a potential therapeutic target in breast cancerWieslawa H Dragowska, Sherry A Weppler, Jun Chih Wang, et al.
Molecular Cancer Therapeutics|March 7, 2007
Modulation of cancer cell survival pathways using multivalent liposomal therapeutic antibody constructsGigi N C Chiu, Lincoln A Edwards, Anita I Kapanen, et al.
Current Cancer Drug Targets|October 5, 2006
Development and assessment of conventional and targeted drug combinations for use in the treatment of aggressive breast cancersD N Waterhouse, K A Gelmon, R Klasa, et al.
Plos One|March 26, 2013
Nano-encapsulation of arsenic trioxide enhances efficacy against murine lymphoma model while minimizing its impact on ovarian reserve in vitro and in vivoRichard W Ahn, Susan L Barrett, Meera R Raja, et al.
The Journal of Pathology|April 27, 2017
The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic typeYemin Wang, Shary Yuting Chen, Anthony N Karnezis, et al.
Molecular Cancer Therapeutics|January 19, 2008
Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of integrin-linked kinase (ILK)Lincoln A Edwards, Janet Woo, Lynsey A Huxham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Irinophore C, a novel nanoformulation of irinotecan, alters tumor vascular function and enhances the distribution of 5-fluorouracil and doxorubicinJennifer H E Baker, Jeffrey Lam, Alaistair H Kyle, et al.
Pageof 23

Showing results (211-220 of 225) with videos related to

Sort By:
Pageof 23
Inorganic Chemistry|December 15, 2015
Induction of Cytotoxicity in Pyridine Analogues of the Anti-metastatic Ru(III) Complex NAMI-A by Ferrocene FunctionalizationChanghua Mu, Stephanie W Chang, Kathleen E Prosser, et al.
BMC Cancer|October 4, 2011
The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivityWieslawa H Dragowska, Sherry A Weppler, Mohammed A Qadir, et al.
Magnetic Resonance in Medicine|October 10, 2006
Chemodosimetry of in vivo tumor liposomal drug concentration using MRIBenjamin L Viglianti, Ana M Ponce, Charles R Michelich, et al.
Plos One|October 23, 2013
Induction of autophagy is an early response to gefitinib and a potential therapeutic target in breast cancerWieslawa H Dragowska, Sherry A Weppler, Jun Chih Wang, et al.
Molecular Cancer Therapeutics|March 7, 2007
Modulation of cancer cell survival pathways using multivalent liposomal therapeutic antibody constructsGigi N C Chiu, Lincoln A Edwards, Anita I Kapanen, et al.
Current Cancer Drug Targets|October 5, 2006
Development and assessment of conventional and targeted drug combinations for use in the treatment of aggressive breast cancersD N Waterhouse, K A Gelmon, R Klasa, et al.
Plos One|March 26, 2013
Nano-encapsulation of arsenic trioxide enhances efficacy against murine lymphoma model while minimizing its impact on ovarian reserve in vitro and in vivoRichard W Ahn, Susan L Barrett, Meera R Raja, et al.
The Journal of Pathology|April 27, 2017
The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic typeYemin Wang, Shary Yuting Chen, Anthony N Karnezis, et al.
Molecular Cancer Therapeutics|January 19, 2008
Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of integrin-linked kinase (ILK)Lincoln A Edwards, Janet Woo, Lynsey A Huxham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Irinophore C, a novel nanoformulation of irinotecan, alters tumor vascular function and enhances the distribution of 5-fluorouracil and doxorubicinJennifer H E Baker, Jeffrey Lam, Alaistair H Kyle, et al.
Pageof 23